Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-03-25
1997-06-24
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 34, 435 18, 435 29, 435 39, 435 40, 435 51, 536 72, A61K 3170, C07H 1708
Patent
active
056417535
ABSTRACT:
Pharmaceutical compositions of an erythromycin derivative combined with sulfisoxazole according to the structural formulas: ##STR1## where R is hydrogen, C1-C10 alkylcarbonyl or C1-C10 alkyl wherein the substituent is amino or cyano; R1 and R2 are independently hydrogen, hydroxyl or amino; and the pharmaceutical salts and esters thereof.
REFERENCES:
Tarpay et al., Antimicrobial Agents and Chemotherapy, vol. 22, No. 1, pp. 145-147 (1982).
Hughes et al., J. of Infectious Diseases, vol. 170, No. 1, pp. 906-911, (1994).
Doern et al., Antimicrobial Agents and Chemotherapy, vol. 32, No. 2, pp. 180-185 (1988).
O Neill James
Platt Chris E.
Scott Gene
Wilson James O.
LandOfFree
10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-149176